NCT01664910 2024-07-23CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid MalignanciesM.D. Anderson Cancer CenterPhase 1/2 Completed27 enrolled 12 charts
NCT01871675 2016-07-11Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesSCRI Development Innovations, LLCPhase 1 Completed48 enrolled